MR

Mahesh Rameshwar Kalantri

Active Director Director DIN 08081422
DIN 08081422 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Mahesh Rameshwar Kalantri

Data last updated:

Mahesh Rameshwar Kalantri is a Director at Lucida Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Lucida Pharmaceuticals Private Limited reported revenue of ₹5.9 Lakh (FY 2025).

DIN 08081422
Primary Designation Director
Industry Pharma
First Appointment 03 Apr 2018
Oldest Company Age 8 yrs
Largest company Lucida Pharmaceuticals Private Limited · ₹5.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Apr 20182018₹5.9 Lakh (FY 2025)Active

Board colleagues of Mahesh Rameshwar Kalantri

Directorship timeline

Open interactive timeline →
Lucida Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mahesh Rameshwar Kalantri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Rameshwar Kalantri

Mahesh Rameshwar Kalantri currently holds 1 directorship: Lucida Pharmaceuticals Private Limited (Director, since 03 Apr 2018, revenue ₹5.9 Lakh (FY 2025)).

Mahesh Rameshwar Kalantri was first appointed on 03 Apr 2018 as Director at Lucida Pharmaceuticals Private Limited.

The current boards of Mahesh Rameshwar Kalantri's companies include Deepali Rajendra Kalantri (Lucida Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available